1.6.2015
EN
Official Journal of the European Union
C 178/9
Request for a preliminary ruling from the Finanzgericht Hamburg (Germany) lodged on 12 March 2015 — Salutas Pharma GmbH v Hauptzollamt Hannover
(Case C-124/15)
(2015/C 178/09)
Language of the case: German
Referring court
Finanzgericht Hamburg
Parties to the main proceedings
Applicant: Salutas Pharma GmbH
Defendant: Hauptzollamt Hannover
Question referred
Is the Combined Nomenclature in Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and the statistical nomenclature and on the Common Customs Tariff (1), as amended by Commission Regulation (EC) No 1777/2001 of 7 September 2001 (2) to be interpreted as meaning that effervescent tablets with a calcium content of 500 mg per tablet that are used for the prevention and treatment of a calcium deficiency and to support a special therapy for the prevention and treatment of osteoporosis and for which the maximum recommended daily dose for adults indicated on the label is 3 tablets (= 1 500 mg) are to be classified under subheading 3004 9000?
(1) OJ 1987 L 256, p. 1.
(2) OJ 2001 L 240, p. 4.
Full & Egal Universal Law Academy